Sensory,
Teleoperated,
Intuitive

The first fully-robotic
teleoperated system
for endovascular interventions
Sentante

Endovascular procedures performed remotely with uncompromised feedback force

Sentante enables the remote manipulation of catheters and guidewires
for safe and rapid endovascular disease management

Remote interventions reduce the response time for
stroke, heart attack
and bleeding

Sentante new3
Uniqueness
of Sentante:

Disruptive technology:

01

Fully robotic

Sentante new1

The manipulation of three endovascular instruments simultaneously allows the entire procedure to be performed robotically.

02

Teleoperated

Sentante new3
The endovascular procedure can be performed from a different room or hospital.

03

Haptic feedback

best4
Physicians can feel the catheter and guidewire just as if they were standing near the patient

04

Universal compatibility

guidewires
A variety of dedicated catheters and guidewires are compatible, with no dependence on the manufacturer

05

Precise manipulation

Sentante real 1
Accurate, submillimetric instrument positioning and stent placement

06

Ergonomic workplace

Sentante new3
Allows physicians to fully concentrate on an ongoing case without the use of heavy lead aprons

07

No additional training is needed

best4

Physicians interface with the robot is via the same endovascular instruments as in a manual procedure

08

Occupational hazards free

Sentante new3
Medical personnel are not exposed to hazardous X-rays
Future
perspectives

01

Training module

Sentante_6-e1622887039610
Realistic training platform with haptic feedback for residents and new physicians

02

Device testing platform

Simulated models for safe, affordable testing and training of endovascular devices

03

Artificial intelligence based automation

Semi-automated routine tasks such as catheter or guidewire exchange
Sentante new1
About Us


Our vision is to transform healthcare by increasing treatment availability for patients and protecting medical personnel from occupational hazard. Our mission is to bring the world’s first fully-robotic system for endovascular interventions to clinical practice for the benefit of patients, physicians, and hospitals.

Our values People focused. We care about patients, medical personnel, and colleagues. Result-based. We are bringing only evidence-based, new medical solutions to the hospitals.

Innovation driven. Constant research and development of the novel medical solutions. Sustainability in mind. Trying not to destroy the planet while supplying the most advanced healthcare solutions.

Management Team

Edvardas Satkauskas

CEO

Experienced entrepreneur, Co-founder of Inovatyvi Medicina

 

 

Dr. Tomas Baltrūnas

CMO

Vascular surgeon, Founder of Inovatyvi Medicina

Perry Van Rijsingen

Board Member

 

Dr. Evaldas Kalvaitis

COO

Co-founder of Inovatyvi Medicina

 

Vilius Dambrauskas

CTO

Co-founder of Inovatyvi Medicina

Vaidas Labunskas

Chief Mechanical Engineer

Co-founder of Inovatyvi Medicina

Ugnė Gurskė

Human Resources Manager

Advisory Board Members

profile-pic (73)

Dr. Ricardo A. Hanel

Medical Advisory Board Member

bandymas4[4382]

Dr. Michael Lichtenberg

Medical Advisory Board Member

 
David-Liebeskind[4385]

Dr. David Liebeskind

Medical Advisory Board Member

 
Giovanni-gera[4434]

Dr. Giovanni Torsello

Medical Advisory Board Member

 
Peter-Shneider[4388]

Dr. Peter Schneider

Medical Advisory Board Member

profile-pic (37)

Matt Lemay

Business Advisory Board Member

C.Prentice

Christopher Prentice

Business Advisory Board Member

Route to
market

Expecting launch in 2024

01
Inovatyvi Medicina established
Sentante development began
02
First grant received
Lithuanian Business support agency

01
Hard, dedicated work
TRL4 reached
02
H2020 SME phI grant
Awarded a highly competitive grant
03
Perfect New Year’s party
A solid kickstart into 2019
01
First animal test
Proved to manipulate guidewires perfectly
02
TRL4 reached
Positive feedback from physicians
01
Ongoing animal tests
Again, proved to manipulate guidewires and catheters perfectly
02
TRL5 reached
03
First patent application

EPO

01
TRL6 reached
02
Successful stent implantation
Both Rx and OTW
03

First patent application

01

Work in progress

01

Pre-clinical animal testing

02

Continuing patent applications

01

Expected first in human procedure

News

Paris Vascular Insights Symposium, 2023

Paris Vascular Insights Symposium #PVI2023 took center stage at the same venue as Paris Fashion Week! 🌟 While the runway dazzled with style, our very own Tomas Baltrunas rocked the

 MedTech Innovator, California, 2023

Absolutely thrilled to participate in MedTech Innovator, the world’s largest accelerator of medical technology companies and the premier nonprofit startup accelerator in the medical technology industry.

 ICCA Stroke Conference, 2023

Sentante presented at ICCA Stroke Conference, 2023 – thrilling! ICCA Stroke brought together leading minds in the field to discuss groundbreaking advancements in stroke research and treatment. 🎯All united

Leipzig Interventional Course #LINC23!

Incredible opportunity to unveil the first-ever fully robotic endovascular thrombectomy procedure at the Leipzig Interventional Course #LINC23! During presentation, Tomas Baltrunas highlighted the tremendous promise of incorporating robotics